{"presentation":{"slides":[{"elements":[{"x":15.468409586056646,"y":4.086021505376344,"width":70.69716775599129,"height":93.76344086021504,"action":{"library":"H5P.Image 1.1","params":{"decorative":false,"contentName":"Image","expandImage":"Expand Image","minimizeImage":"Minimize Image","file":{"path":"images\/file-672922ce84de3.png","mime":"image\/png","copyright":{"license":"U"},"width":1237,"height":831}},"subContentId":"f648af39-b98a-4170-ac92-ac812fb49032","metadata":{"contentType":"Image","license":"U","title":"Untitled Image"}},"alwaysDisplayComments":false,"backgroundOpacity":0,"displayAsButton":false,"buttonSize":"big","goToSlideType":"specified","invisible":false,"solution":""},{"x":3.2679738562091503,"y":12.903225806451612,"width":29.62962962962963,"height":32.68817204301075,"action":{"library":"H5P.AdvancedText 1.1","params":{"text":"

The BPaLM regimen <\/strong>is a six-month, all-oral treatment for drug-resistant tuberculosis (DR-TB). This regimen is a combination of four drugs: Bedaquiline (B), Pretomanid (Pa), Linezolid (L), and Moxifloxacin (M) - BPaLM.<\/span><\/span><\/p>\n"},"subContentId":"b823691e-510e-4822-a2eb-012ba80c92f3","metadata":{"contentType":"Text","license":"U","title":"Untitled Text"}},"alwaysDisplayComments":false,"backgroundOpacity":0,"displayAsButton":false,"buttonSize":"big","goToSlideType":"specified","invisible":false,"solution":""},{"x":68.6260348583878,"y":15.031354838709676,"width":30.28322440087146,"height":23.65591397849462,"action":{"library":"H5P.AdvancedText 1.1","params":{"text":"

BPaLM regimen must be the first choice of treatment in eligible patients<\/strong> with MDR\/RR-TB regardless of their FQ resistance status or HIV status.<\/span><\/span><\/p>\n"},"metadata":{"contentType":"Text","license":"U","title":"Untitled Text"},"subContentId":"b40b8da0-d3e0-4604-8573-e9db290a52ad"},"alwaysDisplayComments":false,"backgroundOpacity":0,"displayAsButton":false,"buttonSize":"big","goToSlideType":"specified","invisible":false,"solution":""},{"x":3.265141612200436,"y":64.43763440860215,"width":31.59041394335512,"height":30.10752688172043,"action":{"library":"H5P.AdvancedText 1.1","params":{"text":"

This regimen has several benefits<\/strong>, including a shorter duration than traditional MDR-TB treatments, lower cost, reduced pill burden, high efficacy, improved compliance and clinical outcomes.<\/span><\/span><\/p>\n"},"metadata":{"contentType":"Text","license":"U","title":"Untitled Text"},"subContentId":"d934e6ff-3a3a-4506-9fa2-8574112858a6"},"alwaysDisplayComments":false,"backgroundOpacity":0,"displayAsButton":false,"buttonSize":"big","goToSlideType":"specified","invisible":false,"solution":""},{"x":68.6260348583878,"y":68.7331182795699,"width":31.372549019607845,"height":21.50537634408602,"action":{"library":"H5P.AdvancedText 1.1","params":{"text":"

During the trials, BPaLM regimen showed favorable efficacy and safety <\/strong>compared to the regimens given in the control arms.<\/span><\/span><\/p>\n"},"metadata":{"contentType":"Text","license":"U","title":"Untitled Text"},"subContentId":"b72a9570-9c95-4dab-a58c-ddf47d79e0b3"},"alwaysDisplayComments":false,"backgroundOpacity":0,"displayAsButton":false,"buttonSize":"big","goToSlideType":"specified","invisible":false,"solution":""},{"x":35.947712418300654,"y":25.806451612903224,"width":6.5359477124183005,"height":12.903225806451612,"action":{"library":"H5P.Image 1.1","params":{"decorative":false,"contentName":"Image","expandImage":"Expand Image","minimizeImage":"Minimize Image","file":{"path":"images\/file-6729238a53489.png","mime":"image\/png","copyright":{"license":"U"},"width":128,"height":128}},"subContentId":"1a76e122-0359-455a-80e5-1471a10bde3f","metadata":{"contentType":"Image","license":"U","title":"Untitled Image"}},"alwaysDisplayComments":false,"backgroundOpacity":0,"displayAsButton":false,"buttonSize":"big","goToSlideType":"specified","invisible":false,"solution":""},{"x":35.947712418300654,"y":60.21505376344086,"width":6.532286643270193,"height":12.903225806451612,"action":{"library":"H5P.Image 1.1","params":{"decorative":false,"contentName":"Image","expandImage":"Expand Image","minimizeImage":"Minimize Image","file":{"path":"images\/file-6729240b2b541.png","mime":"image\/png","copyright":{"license":"U"},"width":512,"height":512}},"metadata":{"contentType":"Image","license":"U","title":"Untitled Image"},"subContentId":"887080c1-87f5-4944-afd5-a8f791401a15"},"alwaysDisplayComments":false,"backgroundOpacity":0,"displayAsButton":false,"buttonSize":"big","goToSlideType":"specified","invisible":false,"solution":""},{"x":59.58605664488017,"y":27.741935483870964,"width":6.532286643270193,"height":12.903225806451612,"action":{"library":"H5P.Image 1.1","params":{"decorative":false,"contentName":"Image","expandImage":"Expand Image","minimizeImage":"Minimize Image","file":{"path":"images\/file-672923c62e7b1.png","mime":"image\/png","copyright":{"license":"U"},"width":128,"height":128}},"metadata":{"contentType":"Image","license":"U","title":"Untitled Image"},"subContentId":"7b4fea2a-7db1-4722-842a-41d2218b4233"},"alwaysDisplayComments":false,"backgroundOpacity":0,"displayAsButton":false,"buttonSize":"big","goToSlideType":"specified","invisible":false,"solution":""},{"x":44.66230936819172,"y":45.16129032258064,"width":15.250544662309368,"height":19.354838709677416,"action":{"library":"H5P.AdvancedText 1.1","params":{"text":"

BPaLM regimen for DR-TB<\/strong><\/p>\n"},"subContentId":"2a7b3cf2-4a35-4088-9c59-307abea3a498","metadata":{"contentType":"Text","license":"U","title":"Untitled Text"}},"alwaysDisplayComments":false,"backgroundOpacity":0,"displayAsButton":false,"buttonSize":"big","goToSlideType":"specified","invisible":false,"solution":""},{"x":59.912854030501094,"y":61.72043010752688,"width":5.446623093681917,"height":10.75268817204301,"action":{"library":"H5P.Image 1.1","params":{"decorative":false,"contentName":"Image","expandImage":"Expand Image","minimizeImage":"Minimize Image","file":{"path":"images\/file-672924a1d40ad.png","mime":"image\/png","copyright":{"license":"U"},"width":128,"height":128}},"metadata":{"contentType":"Image","license":"U","title":"Untitled Image"},"subContentId":"b8f53bb6-b7a0-4581-9ed3-d2feb6c39459"},"alwaysDisplayComments":false,"backgroundOpacity":0,"displayAsButton":false,"buttonSize":"big","goToSlideType":"specified","invisible":false,"solution":""}],"slideBackgroundSelector":{}}],"keywordListEnabled":true,"globalBackgroundSelector":{},"keywordListAlwaysShow":false,"keywordListAutoHide":false,"keywordListOpacity":90},"override":{"activeSurface":false,"hideSummarySlide":false,"summarySlideSolutionButton":true,"summarySlideRetryButton":true,"enablePrintButton":false,"social":{"showFacebookShare":false,"facebookShare":{"url":"@currentpageurl","quote":"I scored @score out of @maxScore on a task at @currentpageurl."},"showTwitterShare":false,"twitterShare":{"statement":"I scored @score out of @maxScore on a task at @currentpageurl.","url":"@currentpageurl","hashtags":"h5p, course"},"showGoogleShare":false,"googleShareUrl":"@currentpageurl"}},"l10n":{"slide":"Slide","score":"Score","yourScore":"Your Score","maxScore":"Max Score","total":"Total","totalScore":"Total Score","showSolutions":"Show solutions","retry":"Retry","exportAnswers":"Export text","hideKeywords":"Hide sidebar navigation menu","showKeywords":"Show sidebar navigation menu","fullscreen":"Fullscreen","exitFullscreen":"Exit fullscreen","prevSlide":"Previous slide","nextSlide":"Next slide","currentSlide":"Current slide","lastSlide":"Last slide","solutionModeTitle":"Exit solution mode","solutionModeText":"Solution Mode","summaryMultipleTaskText":"Multiple tasks","scoreMessage":"You achieved:","shareFacebook":"Share on Facebook","shareTwitter":"Share on Twitter","shareGoogle":"Share on Google+","summary":"Summary","solutionsButtonTitle":"Show comments","printTitle":"Print","printIngress":"How would you like to print this presentation?","printAllSlides":"Print all slides","printCurrentSlide":"Print current slide","noTitle":"No title","accessibilitySlideNavigationExplanation":"Use left and right arrow to change slide in that direction whenever canvas is selected.","accessibilityCanvasLabel":"Presentation canvas. Use left and right arrow to move between slides.","accessibilityProgressBarLabel":"Choose slide to display","containsNotCompleted":"@slideName contains not completed interaction","containsCompleted":"@slideName contains completed interaction","slideCount":"Slide @index of @total","containsOnlyCorrect":"@slideName only has correct answers","containsIncorrectAnswers":"@slideName has incorrect answers","shareResult":"Share Result","accessibilityTotalScore":"You got @score of @maxScore points in total","accessibilityEnteredFullscreen":"Entered fullscreen","accessibilityExitedFullscreen":"Exited fullscreen","confirmDialogHeader":"Submit your answers","confirmDialogText":"This will submit your results, do you want to continue?","confirmDialogConfirmText":"Submit and see results","slideshowNavigationLabel":"Slideshow navigation"}}

Search

BPaLM regimen for DR-TB

Content Status

Type

Linked Node

BPaLM regimen for DR-TB

Content Creator

Reviewer